Jan Marini CelluliTx 114g
Order within 23 hrs, 9 mins
- In Stock
- Free Delivery
- Express Delivery
Product Description
Cellulite isn't the end of the world; it's something that 80-90% of women suffer with regardless of size or lifestyle choice. However, if you're looking to take back a little extra control when it comes to those cute dimples, we recommend the Jan Marini CelluliTx solution.
This breakthrough formula helps to combat the severity of dimpled skin, also known as cellulite. A mix of 11 key ingredients work in synergy to dynamically target the appearance of cellulite. Caffeine, aminophylline, l-carnitine, theophylline, peptides, glaucine, retinol and other key ingredients grace the formula, creating a tingling sensation that counteracts the harsh appearance of cellulite.
Smooth, hydrate and revitalise dimpled skin with this targeted treatment, here at Cosmetify.
Written by Ellie Child, Beauty Editor
Product details
Skin Type: Formulated for all skin types
Ingredient Highlights: Contains biotin, caffeine, citric acid, glycerin, peptides, retinol and vitamin a.
Formulated without: Ammonia, parabens, phthalates and sulphates.
Ingredient Features
If you're looking to protect against UV rays and toxins and to produce a radiant complexion that looks noticeably younger then the retinol contained in this Jan Marini cellulite treatment item is a great solution for you. There is also vitamin a contained in this item which helps to ensure overall skin radiance and to repair skin tissue.
How do you use it?
- Apply the lotion once daily for the first week, then increase usage as tolerated to two times daily
- If irritation occurs, decrease cream application frequency to allow the skin greater time to acclimate
Delivery & Returns
This product is eligible for free standard delivery with Face The Future. Orders are expected to arrive 1-5 days after dispatch. Express/Next day delivery option available. Shipping available to UK addresses only.
The returns policy for this retailer is around 14 days, see their website for further information.
